# Mass Screening and Treatment for Reduction of Falciparum Malaria

> **NCT04093765** · NA · COMPLETED · sponsor: **University of Oxford** · enrollment: 5542 (actual)

## Conditions studied

- Plasmodium Falciparum Malaria

## Interventions

- **DIAGNOSTIC_TEST:** Ultrasensitive Rapid Diagnostic Test (URDT)
- **DRUG:** Antimalarials

## Key facts

- **NCT ID:** NCT04093765
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-01
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 5542 (ACTUAL)
- **Last updated:** 2024-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04093765

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04093765, "Mass Screening and Treatment for Reduction of Falciparum Malaria". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04093765. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*